Startup · Canada
Avivo Biomedical Inc
HQ Vancouver, CanadaFounded 20201-10 employeesUpdated
Blood-conversion biotechnology for transfusion applications.
Funding3 rounds
- Equity raised
- Undisclosed
- Debt, secondaries & grants
- $250K
- Latest
- UndisclosedSeed · Jun 23, 2022
| Announced | Stage | Amount | Valuation | Lead investors | Other investors | Confidence |
|---|---|---|---|---|---|---|
| Jun 23, 2022 | Seed | Undisclosed | — | — | — | Confirmed |
| Mar 31, 2022 | Grant | $250K | — | — | — | Reported |
| 2021 | Pre-Seed | Undisclosed | — | — | — | Reported |
- SeedConfirmedUndisclosedJun 23, 2022
- Grant$250KMar 31, 2022
- Pre-SeedUndisclosed2021
Raised counts equity rounds; debt, secondary sales and grants are totaled separately. Amounts in other currencies are converted at the announcement month's average rate. A ~ marks an estimated or converted amount.
Capabilities1
| Technology | Role | Maturity | TRL | Notes | Confidence |
|---|---|---|---|---|---|
| Biotechnology and biomanufacturing | Developer | — | — | classify_sectors run 52, haiku, taxonomy 2026-10-18b: Blood-conversion enzymes described as dual-use at the intersection of military trauma care, and selected for NATO DIANA. | Reported |
- Developerclassify_sectors run 52, haiku, taxonomy 2026-10-18b: Blood-conversion enzymes described as dual-use at the intersection of military trauma care, and selected for NATO DIANA.—Reported
Maturity and TRL describe this organization's work; the field-wide maturity is on each technology's page.
People4
| Person | Role |
|---|---|
| Geoff Houlton · LinkedIn ↗ | Founder |
| John Barclay · LinkedIn ↗ | Co-Founder & Vice President, Business Development |
| Geoff Houlton · LinkedIn ↗ | President & CEO |
| John Coleman · LinkedIn ↗ | President and CEO |
Company Metrics
Employee-profile counts reflect LinkedIn profiles associated with the company, not verified headcount. One observation establishes a baseline; it does not establish growth.
Sources6
Profile2
- 1
bouncewatch.com · Supports Organization · kind
“Funding Stage Seed”
- 2Government recordNATO DIANA | Official Website
NATO DIANA · Supports Organization
“Whole-Blood Conversion Unit capable of converting A, B and AB-type whole blood into universal blood”
Funding3
- 3
BusinessWire (via BioSpace) · Jun 23, 2022 · Supports Funding round, Organization · ownership
“This funding builds upon a pre-seed financing completed in February 2021”
- 4
Crunchbase · Supports Funding round, Organization · employee range, Role
“Pre Seed - ABOzymes”
- 5
LinkedIn · Supports Funding round, Organization · employee range, Organization · hq region, Organization · linkedin url
“funding round: Grant, 2022-03-31, USD 250,000, lead: Genome British Columbia”
Other1
- 6
LinkedIn via Bright Data · Supports Organization · founded, Organization · headquarters, Organization · logo, Organization · url, Organization metric · employees in linkedin, Organization metric · followers
“{"founded": 2020}”
Each fact on this page is attached to the sources that support it. Archived copies are linked when we keep one.